Janus-faced course of COVID-19 infection in patients with hematological malignancies.

Bellmann-Weiler, Rosa; Burkert, Francesco; Schwaiger, Theresa; Schmidt, Stephan; Ludescher, Christof; Oexle, Horst; Wolf, Dominik; Weiss, Günter

Bellmann-Weiler, Rosa; Burkert, Francesco; Schwaiger, Theresa; Schmidt, Stephan; Ludescher, Christof; Oexle, Horst; Wolf, Dominik; Weiss, Günter.

Affiliation

Bellmann-Weiler R; Department of Internal Medicine II, Medical University of Innsbruck, Innsbruck, Austria.
Burkert F; Department of Internal Medicine II, Medical University of Innsbruck, Innsbruck, Austria.
Schwaiger T; Department of Internal Medicine V, Medical University of Innsbruck, Innsbruck, Austria.
Schmidt S; Department of Internal Medicine V, Medical University of Innsbruck, Innsbruck, Austria.
Ludescher C; Outpatient Clinic for Hematology and Oncology, Innsbruck, Austria.
Oexle H; Department of Internal Medicine, District Hospital Hall, Hall, Austria.
Wolf D; Department of Internal Medicine V, Medical University of Innsbruck, Innsbruck, Austria.
Weiss G; Department of Internal Medicine II, Medical University of Innsbruck, Innsbruck, Austria.

Eur J Haematol ; 105(4): 502-504, 2020 Oct.

Article de En | MEDLINE | ID: mdl-32557918

Sujet(s)
Mots clés

acute myeloid leukemia; immunology and infectious diseases; non-Hodgkin's lymphoma

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Leucémie aigüe myéloïde / Leucémie à tricholeucocytes / Lymphome B / Lymphome folliculaire / Immunosuppression thérapeutique / COVID-19 / Hypoxie Type d'étude: Etiology_studies Limites: Humans / Male Langue: En Journal: Eur J Haematol Sujet du journal: HEMATOLOGIA Année: 2020 Type de document: Article Pays d'affiliation: Autriche

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google